Rockwell Medical (RMTI) Receivables - Other (2014 - 2022)

Rockwell Medical has reported Receivables - Other for 8 years, with the latest figure at $7.4 million in Q3 2022.

• For the quarter ending Q3 2022, Receivables - Other rose 22.05% year-over-year to $7.4 million; the trailing twelve-month figure through Sep 2022 stood at $7.4 million (up 22.05% YoY), and the FY2021 full-year result was $5.9 million, up 41.76% from the prior year.
• Receivables - Other for Q3 2022 stood at $7.4 million, down from $8.1 million in the prior quarter.
• The five-year high for Receivables - Other was $8.1 million in Q2 2022, with the low at $5122.0 in Q3 2019.
• Historically, Receivables - Other has averaged $4.2 million across 5 years, with a median of $4.4 million in 2019.
• Annual changes were most pronounced in 2019 — Receivables - Other sank 99.93% — and 2020, when it surged 80513.04%.
• Rockwell Medical's Receivables - Other stood at $371217.0 in 2018, then jumped by 1032.22% to $4.2 million in 2019, then decreased by 0.76% to $4.2 million in 2020, then soared by 41.76% to $5.9 million in 2021, then increased by 24.59% to $7.4 million in 2022.
• The last three Receivables - Other figures came in at $7.4 million (Q3 2022), $8.1 million (Q2 2022), and $7.1 million (Q1 2022), per Business Quant data.